ES525239A0 - Un procedimiento para la preparacion de derivados del acido ascorbico - Google Patents
Un procedimiento para la preparacion de derivados del acido ascorbicoInfo
- Publication number
- ES525239A0 ES525239A0 ES525239A ES525239A ES525239A0 ES 525239 A0 ES525239 A0 ES 525239A0 ES 525239 A ES525239 A ES 525239A ES 525239 A ES525239 A ES 525239A ES 525239 A0 ES525239 A0 ES 525239A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- ascorbic acid
- acid derivatives
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33934482A | 1982-01-15 | 1982-01-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES525239A0 true ES525239A0 (es) | 1985-01-16 |
| ES8502698A1 ES8502698A1 (es) | 1985-01-16 |
Family
ID=23328588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES518968A Expired ES8403118A1 (es) | 1982-01-15 | 1983-01-13 | Un procedimiento para la preparacion de derivados del acido ascorbico. |
| ES525239A Expired ES8502698A1 (es) | 1982-01-15 | 1983-08-30 | Un procedimiento para la preparacion de derivados del acido ascorbico |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES518968A Expired ES8403118A1 (es) | 1982-01-15 | 1983-01-13 | Un procedimiento para la preparacion de derivados del acido ascorbico. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0086554A1 (es) |
| JP (1) | JPS58131978A (es) |
| KR (1) | KR840003247A (es) |
| AU (1) | AU1035183A (es) |
| CA (1) | CA1181078A (es) |
| DD (1) | DD209455A5 (es) |
| DK (1) | DK14283A (es) |
| ES (2) | ES8403118A1 (es) |
| FI (1) | FI830078A7 (es) |
| GB (1) | GB2114571A (es) |
| GR (1) | GR77897B (es) |
| IL (1) | IL67646A0 (es) |
| PL (1) | PL240125A1 (es) |
| PT (1) | PT76083B (es) |
| RO (1) | RO86439B (es) |
| ZA (1) | ZA83173B (es) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552895A (en) * | 1983-03-14 | 1985-11-12 | Eli Lilly And Company | Furo[3,2-b]furan-2-(3H)-ones |
| JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
| WO1986007592A1 (en) * | 1985-06-18 | 1986-12-31 | Takeda Chemical Industries, Ltd. | Ascorbic acid derivatives, process for their preparation, and preparations containing same |
| WO1986006720A1 (en) * | 1985-05-17 | 1986-11-20 | Takeda Chemical Industries, Ltd. | Ascorbic acid derivatives, production thereof, and pharmaceutical preparation therefrom |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| JPS60139619A (ja) * | 1983-12-27 | 1985-07-24 | Mutsuyuki Kochi | Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤 |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| ES2099064T3 (es) | 1988-09-01 | 1997-05-16 | Takeda Chemical Industries Ltd | Derivados de fumagillol. |
| DE69024193T2 (de) * | 1989-09-11 | 1996-05-30 | Nippon Hypox Lab Inc | Ascorbinsäure-derivate |
| US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
| JP3206602B2 (ja) * | 1990-03-07 | 2001-09-10 | エフ・ホフマン―ラ ロシユ アーゲー | アスコルビン酸の誘導体の製造方法 |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| JPH0429989A (ja) * | 1990-05-24 | 1992-01-31 | Nisshin Flour Milling Co Ltd | Ｌ―アスコルビン酸誘導体の製造法 |
| GB9026114D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | New compounds |
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| RU2126398C1 (ru) * | 1993-02-05 | 1999-02-20 | Плива, Фармацеутска, Кемийска, Прехрамбена и Козметичка Индустрия Дионичко Друштво Загреб | Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты |
| US5629327A (en) | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| DE69738935D1 (de) | 1996-11-05 | 2008-10-02 | Childrens Medical Center | Zusammensetzungen enthaltend Thalidomide und Dexamethason für die Behandlung von Krebs |
| EP0875246A1 (en) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer |
| WO1999050258A1 (en) * | 1998-03-27 | 1999-10-07 | Lg Chemical Ltd. | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| US6673828B1 (en) | 1998-05-11 | 2004-01-06 | Children's Medical Center Corporation | Analogs of 2-Phthalimidinoglutaric acid |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| WO2001056566A1 (fr) * | 2000-02-01 | 2001-08-09 | Mutsuyuki Kochi | Compositions inhibitrices de neovascularisation et procede correspondant |
| SK13902002A3 (sk) * | 2000-03-31 | 2003-05-02 | Angiogene Pharmaceuticals Ltd. | Liečivo obsahujúce činidlá poškodzujúce cievy, kit, ktorý toto liečivo obsahuje, a použitie liečiva |
| WO2003010173A1 (en) * | 2001-07-26 | 2003-02-06 | Tagra Biotechnologies Ltd. | Stabilized derivatives of ascorbic acid -3-phosphate |
| US7977379B2 (en) | 2002-05-15 | 2011-07-12 | Bhn Co., Ltd. | Method for angiogenesis inhibition or immunostimulation |
| EP1939192A1 (en) * | 2006-12-28 | 2008-07-02 | Neuropharma S.A. | Cyclopentanone derivatives, method of synthesis and uses thereof |
| FR2955493B1 (fr) * | 2010-01-28 | 2012-02-24 | Oreal | Utilisation de derives d'acide ascorbique en coloration des fibres keratiniques humaines, composition les comprenant, procede de coloration et dispositif |
| JP5602456B2 (ja) * | 2010-02-24 | 2014-10-08 | 日本精化株式会社 | アスコルビン酸誘導体 |
| US9550744B2 (en) * | 2013-09-25 | 2017-01-24 | University Of Florida Research Foundation, Inc. | Vitamin C prodrugs and uses thereof |
| US10105407B2 (en) * | 2015-06-09 | 2018-10-23 | John P. Crow, JR. | Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof |
| EP3383429B1 (en) | 2015-11-30 | 2020-10-14 | INSERM - Institut National de la Santé et de la Recherche Médicale | Nmdar antagonists for the treatment of tumor angiogenesis |
-
1983
- 1983-01-10 FI FI830078A patent/FI830078A7/fi not_active Application Discontinuation
- 1983-01-10 IL IL67646A patent/IL67646A0/xx unknown
- 1983-01-10 RO RO109663A patent/RO86439B/ro unknown
- 1983-01-11 PT PT76083A patent/PT76083B/pt unknown
- 1983-01-11 ZA ZA83173A patent/ZA83173B/xx unknown
- 1983-01-11 CA CA000419220A patent/CA1181078A/en not_active Expired
- 1983-01-12 PL PL24012583A patent/PL240125A1/xx unknown
- 1983-01-12 DD DD83247195A patent/DD209455A5/de unknown
- 1983-01-13 GR GR70253A patent/GR77897B/el unknown
- 1983-01-13 GB GB08300907A patent/GB2114571A/en not_active Withdrawn
- 1983-01-13 JP JP58005144A patent/JPS58131978A/ja active Pending
- 1983-01-13 EP EP83300174A patent/EP0086554A1/en not_active Ceased
- 1983-01-13 ES ES518968A patent/ES8403118A1/es not_active Expired
- 1983-01-13 AU AU10351/83A patent/AU1035183A/en not_active Abandoned
- 1983-01-14 DK DK14283A patent/DK14283A/da not_active Application Discontinuation
- 1983-01-14 KR KR1019830000115A patent/KR840003247A/ko not_active Ceased
- 1983-08-30 ES ES525239A patent/ES8502698A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK14283D0 (da) | 1983-01-14 |
| FI830078L (fi) | 1983-07-16 |
| FI830078A0 (fi) | 1983-01-10 |
| PT76083B (en) | 1986-01-09 |
| EP0086554A1 (en) | 1983-08-24 |
| ES518968A0 (es) | 1984-03-01 |
| ES8403118A1 (es) | 1984-03-01 |
| PT76083A (en) | 1983-02-01 |
| GB2114571A (en) | 1983-08-24 |
| CA1181078A (en) | 1985-01-15 |
| GR77897B (es) | 1984-09-25 |
| PL240125A1 (en) | 1984-04-24 |
| DK14283A (da) | 1983-07-16 |
| ES8502698A1 (es) | 1985-01-16 |
| JPS58131978A (ja) | 1983-08-06 |
| RO86439A (ro) | 1985-03-15 |
| DD209455A5 (de) | 1984-05-09 |
| RO86439B (ro) | 1985-03-31 |
| ZA83173B (en) | 1984-08-29 |
| KR840003247A (ko) | 1984-08-20 |
| IL67646A0 (en) | 1983-05-15 |
| AU1035183A (en) | 1983-07-21 |
| GB8300907D0 (en) | 1983-02-16 |
| FI830078A7 (fi) | 1983-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES525239A0 (es) | Un procedimiento para la preparacion de derivados del acido ascorbico | |
| ES524495A0 (es) | Procedimiento para la preparacion de derivados del acido metilendifosfonico | |
| ES521337A0 (es) | Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico. | |
| ES499856A0 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3-2-0) hept-2-en-2-carboxilico | |
| ES505679A0 (es) | Un procedimiento para la preparacion de derivados de acido carbamico | |
| ES533495A0 (es) | Procedimiento para la preparacion de derivados del acido oxamidico | |
| MX7101E (es) | Procedimiento para la preparacion de derivados de acido quinolin-carboxilico | |
| ES500253A0 (es) | Un procedimiento para la preparacion de nuevos derivados del acido 2-penem-3-carboxilico. | |
| ES527807A0 (es) | Un procedimiento para la preparacion de derivados del acido beta-hidroxibutirico gamma-sustituidos | |
| ES521429A0 (es) | Un procedimiento para la preparacion de derivados del acido tetrahidrofurancarboxilico. | |
| ES502828A0 (es) | Un procedimiento para la preparacion de derivados del acido penen-3-carboxilico. | |
| ES500322A0 (es) | Procedimiento para la preparacion de un acido bencenocarbo- xilico | |
| ES538029A0 (es) | Procedimiento para la preparacion de derivados del acido indolacetico | |
| ES510694A0 (es) | Un procedimiento para preparar derivados del acido ascorbico. | |
| ES545565A0 (es) | Un procedimiento para la preparacion de derivados del acido fenil nonatetraenoico | |
| ES523664A0 (es) | Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico. | |
| ES538906A0 (es) | Un procedimiento para la preparacion de nuevos derivados del acido tiazolilacetico. | |
| ES504287A0 (es) | Un procedimiento para la preparacion de derivados del acido monico. | |
| ES506798A0 (es) | Un procedimiento para la preparacion de derivados del acido amino ciclopropilcarboxilico. | |
| ES486465A0 (es) | Un procedimiento para la preparacion de derivados del acido oxisustituido-ciclohexilacetico | |
| ES525238A0 (es) | Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos. | |
| ES529350A0 (es) | Procedimiento para la preparacion de derivados de acido 5-fenilcarbamoilbarbiturico | |
| ES498717A0 (es) | Un procedimiento para la preparacion de derivados del acido 2-b-clorometil-2&-metilpenam-3&-carboxilico. | |
| ES488136A0 (es) | Un procedimiento para la preparacion de derivados del acido monico | |
| ES508208A0 (es) | Un procedimiento para la preparacion de nuevos derivados del acido clavulanico. |